{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T20:43:37Z","timestamp":1698007417818},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"712","license":[{"start":{"date-parts":[[1985,2,1]],"date-time":"1985-02-01T00:00:00Z","timestamp":476064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1985,2,1]]},"DOI":"10.1136\/pgmj.61.712.109","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T20:58:16Z","timestamp":1230584296000},"page":"109-116","source":"Crossref","is-referenced-by-count":19,"title":["Controversies in the treatment of plasma cell myeloma"],"prefix":"10.1093","volume":"61","author":[{"given":"D E","family":"Bergsagel","sequence":"first","affiliation":[{"name":"University of Toronto and Ontario Cancer Institute , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1985,2,1]]},"reference":[{"key":"ref_1","first-page":"1273","article-title":"Phase III study of intermittent carmustine (BCNU) cyclophosphamide and prednisone versus melphalan and prednisone in multiple myeloma","volume":"66","author":"ABRAMSON, N.; LURIE, P.; MIETLOWSKI, W.L.; SCHILL-ING, A.; BENNETT, J.M.; HORTON, J.","year":"1982","unstructured":"ABRAMSON, N., LURIE, P., MIETLOWSKI, W.L., SCHILL-ING, A., BENNETT, J.M. & HORTON, J. (1982). Phase III study of intermittent carmustine (BCNU) cyclophosphamide and prednisone versus melphalan and prednisone in multiple myeloma. Cancer Treatment Reports, 66, 1273.","journal-title":"Cancer Treatment Reports"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/1097-0142(19840201)53:3<583::AID-CNCR2820530336>3.0.CO;2-1","article-title":"Chemotherapy for multiple myeloma","volume":"53","author":"ALEXANIAN, R.; DREICER, R.","year":"1984","unstructured":"ALEXANIAN, R. & DREICER, R. (1984). Chemotherapy for multiple myeloma. Cancer, 53, 583.","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO;2-C","article-title":"Combination chemotherapy for multiple myeloma","volume":"30","author":"ALEXANIAN, R.; GEHAN, E.; BONNET, J.; HAUT, A.; HEWLETT, J.; LANE, M.; McKELVEY, E.M.; MIGLIORE, P.H.; STUCKEY, W.J.; WILSON, H.E.","year":"1972","unstructured":"ALEXANIAN, R., GEHAN, E., BONNET, J., HAUT, A., HEWLETT, J., LANE, M., McKELVEY, E.M., MIGLIORE, P.H., STUCKEY, W.J. & WILSON, H.E. (1972). Combination chemotherapy for multiple myeloma. Cancer, 30, 382.","journal-title":"Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood.V51.6.1005.1005","article-title":"Unmaintained remissions in multiple myeloma","volume":"51","author":"ALEXANIAN, R.; GEHAN, E.; HAUT, A.; SAIKI, J.; WEICK, J.","year":"1978","unstructured":"ALEXANIAN, R., GEHAN, E., HAUT, A., SAIKI, J. & WEICK, J. (1978). Unmaintained remissions in multiple myeloma. Blood, 51, 1005.","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.V62.3.572.572","article-title":"Prednisone pulse therapy for refractory myeloma","volume":"62","author":"ALEXANIAN, R.; YAP, B.S.; BODEY, G.P.","year":"1983","unstructured":"ALEXANIAN, R., YAP, B.S. & BODEY, G.P. (1983). Prednisone pulse therapy for refractory myeloma. Blood, 62, 572.","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","article-title":"Effective treatment of advanced multiple myeloma refractory to alkylating agents","volume":"310","author":"BARLOGIE, B.; SMITH, L.; ALEXANIAN, R.","year":"1984","unstructured":"BARLOGIE, B., SMITH, L. & ALEXANIAN, R. (1984). Effective treatment of advanced multiple myeloma refractory to alkylating agents. New England Journal of Medicine, 310, 1353.","journal-title":"New England Journal of Medicine"},{"issue":"268","key":"ref_7","series-title":"Proceedings of the American Society of Clinical Oncology; Is multidrug chemotherapy necessary for multiple myeloma","first-page":"81","article-title":"The role of maintenance chemotherapy for multiple myeloma","volume":"3","author":"SHELLEY, W.","year":"1984","unstructured":"SHELLEY, W. (1984). The role of maintenance chemotherapy for multiple myeloma. Proceedings of the American Society of Clinical Oncology, 3, 268 (abstract c-1050). BERGSAGEL, D.E. (1982). Is multidrug chemotherapy necessary for multiple myeloma? In: Controversies in Oncology, Wiernik, P.H. (Ed), p. 81, John Wiley & Sons: New York."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1200\/JCO.1983.1.8.510","article-title":"Editorial: Progress in the treatment of plasma cell myeloma?","volume":"1","author":"BERGSAGEL, D.E.","year":"1983","unstructured":"BERGSAGEL, D.E. (1983) Editorial: Progress in the treatment of plasma cell myeloma? Journal of Clinical Oncology, 1, 510.","journal-title":"Journal of Clinical Oncology"},{"key":"ref_9","first-page":"247","article-title":"Letter to the Editor","volume":"2","author":"BERGSAGEL, D.E.","year":"1984","unstructured":"BERGSAGEL, D.E. (1984). Letter to the Editor. Journal of Clinical Oncology, 2, 247.","journal-title":"Journal of Clinical Oncology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJM197910043011402","article-title":"The chemotherapy ofplasma cell myeloma and the incidence of acute leukemia","volume":"301","author":"BERGSAGEL, D.E.; BAILEY, A.J.; LANGLEY, G.R.; MAcDON-ALD, R.N.; WHITE, D.R.; MILLER, A.B.","year":"1979","unstructured":"BERGSAGEL, D.E., BAILEY, A.J., LANGLEY, G.R., MAcDON-ALD, R.N., WHITE, D.R. & MILLER, A.B. (1979). The chemotherapy ofplasma cell myeloma and the incidence of acute leukemia. New England Journal of Medicine, 301, 743.","journal-title":"New England Journal of Medicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archinte.1975.00330010174022","article-title":"Treatment of plasma cell myeloma with cytotoxic agents","volume":"135","author":"BERGSAGEL, D.E.; PRUZANSKI, W.","year":"1975","unstructured":"BERGSAGEL, D.E. & PRUZANSKI, W. (1975). Treatment of plasma cell myeloma with cytotoxic agents. Archives of Internal Medicine, 135, 172.","journal-title":"Archives of Internal Medicine"},{"key":"ref_12","article-title":"Plasma cell neoplasms. In Cancer: Principles and Practice","author":"BERGSAGEL, D.E.; RIDER, W.D.","year":"1985","unstructured":"BERGSAGEL, D.E. & RIDER, W.D. (1985). Plasma cell neoplasms. In Cancer: Principles and Practice ofOncology, DeVita, V.T., Hellman, S. & Rosenberg, S. (Eds), 2nd Edition. Lippincot: Philadelphia and Toronto (in press)."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.1982.tb03935.x","article-title":"Longterm survival in myelomatosis. A report to the M RC working party on leukaemia in adults","volume":"52","author":"BUCKMAN, R.; CUZICK, J.; GALTON, D.A.G.","year":"1982","unstructured":"BUCKMAN, R., CUZICK, J. & GALTON, D.A.G. (1982). Longterm survival in myelomatosis. A report to the M RC working party on leukaemia in adults. British Journal of Haematology, 52, 589.","journal-title":"British Journal of Haematology"},{"key":"ref_14","first-page":"897","article-title":"Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol","volume":"63","year":"1977","unstructured":"CASE, D.C. JR, LEE, B.J., III & CLARKSON, B.D. (1977). Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. American Journal ofMedicine, 63, 897.","journal-title":"American Journal ofMedicine"},{"key":"ref_15","first-page":"73","article-title":"Comparison of two combination chemotherapy regimens for multiple myeloma: methyl-CCNU, cyclophosphamide and prednisone versus melphalan and prednisone","volume":"64","author":"CAVAGNARO, F.; LIEN, J.M.; PAVLOVSKY, S.; BECHERINI, J.O.; PILEGGI, J.E.; MICHEO, E.Q.; JAIT, C.; MUSSO, A.; SUAREZ, A.; PIZZOLATO, M.","year":"1980","unstructured":"CAVAGNARO, F., LIEN, J.M., PAVLOVSKY, S., BECHERINI, J.O., PILEGGI, J.E., MICHEO, E.Q., JAIT, C., MUSSO, A., SUAREZ, A. & PIZZOLATO, M. (1980). Comparison of two combination chemotherapy regimens for multiple myeloma: methyl-CCNU, cyclophosphamide and prednisone versus melphalan and prednisone. Cancer Treatment Reports, 64, 73.","journal-title":"Cancer Treatment Reports"},{"key":"ref_16","article-title":"Proposed guidelines for protocol studies. II Plasma cell myeloma","author":"FORCE, C.H.R.O.N.I.C.L.E.U.K.E.M.I.A.-M.Y.E.L.O.M.A.T.A.S.K.; INSTITUTE, N.A.T.I.O.N.A.L.C.A.N.C.E.R.","year":"1968","unstructured":"CHRONIC LEUKEMIA-MYELOMA TASK FORCE, NATIONAL CANCER INSTITUTE (1968). Proposed guidelines for protocol studies. II Plasma cell myeloma."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJM196411262712202","article-title":"Induction of subacute skeletal fluorosis in a case of multiple myeloma","volume":"271","author":"COHEN, P.; GARDNER, F.H.","year":"1964","unstructured":"COHEN, P. & GARDNER, F.H. (1964). Induction of subacute skeletal fluorosis in a case of multiple myeloma. New England Journal of Medicine, 271, 1129.","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"ref_18","first-page":"21","article-title":"The effectiveness of single versus multiple alkylating agents with and without adriamycin in the primary treatment of multiple myeloma","volume":"62","author":"COOPER, M.R.; McINTYRE, O.R.; ANDERSON, K.; KYLE, R.A.; SILVERFARB, P.; FREI, III, E.","year":"1983","unstructured":"COOPER, M.R., McINTYRE, O.R, ANDERSON, K., KYLE, R.A., SILVERFARB, P. & FREI, E., III. (1983). The effectiveness of single versus multiple alkylating agents with and without adriamycin in the primary treatment of multiple myeloma. Blood 62 (Suppl. 10), 21 la, (abstract, 748).","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V54.1.13.13","article-title":"Improved survival of increased risk myeloma patients on combined triple-alkylating agent therapy: A study of the CALGB","volume":"54","author":"HARLEY, J.P.; PAJAK, T.F.; R., McINTYRE O.; KOCHWA, S.; COOPER, M.R.; M, C.O.L.E.M.A.N.; J, C.U.T.T.N.E.R.","year":"1979","unstructured":"HARLEY, J.P., PAJAK, T.F., McINTYRE. O.R., KOCHWA, S., COOPER, M.R., COLEMAN. M & CUTTNER. J. (1979). Improved survival of increased risk myeloma patients on combined triple-alkylating agent therapy: A study of the CALGB. Blood, 54, 13.","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM197206152862402","article-title":"Ineffectiveness of fluoride therapy in multiple myeloma","volume":"286","year":"1972","unstructured":"HARLEY, J.B., SCHILLING. A. & GLIDWELL, 0. (1972). Ineffectiveness of fluoride therapy in multiple myeloma. New England Journal of Medicine, 286, 1283.","journal-title":"New England Journal of Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jcem-28-6-869","article-title":"Some results of the effect of fluoride on bone tissue in osteoporosis","volume":"28","author":"JOWSEY, J.; SCHENK, R.K.; REUTTER, F.W.","year":"1968","unstructured":"JOWSEY, J., SCHENK, R.K. & REUTTER, F.W. (1968). Some results of the effect of fluoride on bone tissue in osteoporosis. Journal of Clinical Endocrinology and Metabolism, 28, 869.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/1097-0142(19800401)45:7<1669::AID-CNCR2820450724>3.0.CO;2-5","article-title":"Effect of sodium fluoride, calcium carbonate and vitamin D on the skeleton in multiple myeloma","volume":"45","author":"KYLE, R.A.; JOWSEY, J.","year":"1980","unstructured":"KYLE, R.A. & JOWSEY, J. (1980). Effect of sodium fluoride, calcium carbonate and vitamin D on the skeleton in multiple myeloma. Cancer, 45, 1669.","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM197512252932602","article-title":"Multiple myeloma bone disease. The comparative effect of sodium fluoride and calcium carbonate or placebo","volume":"293","author":"KYILE, R.A.; JOWSEY, J.; KELLY, P.J.; TAVES, D.R.","year":"1975","unstructured":"KYILE, R.A., JOWSEY, J., KELLY, P.J. & TAVES, D.R. (1975). Multiple myeloma bone disease. The comparative effect of sodium fluoride and calcium carbonate or placebo. New England Journal of Medicine, 293, 1334.","journal-title":"New England Journal of Medicine"},{"key":"ref_24","first-page":"245","article-title":"Letter to the Editor","volume":"2","author":"LEE, B.J.","year":"1984","unstructured":"LEE, B.J. (1984). Letter to the Editor. Journal of Clinical Oncology, 2, 245.","journal-title":"Journal of Clinical Oncology"},{"key":"ref_25","first-page":"61","article-title":"Intensive treatment of multiple myeloma. In: Controversies in Oncology","author":"LEE, B.J.L.A.K.E.-L.E.W.I.N.; D.; MEYERS, J.E.","year":"1982","unstructured":"LEE, B.J.. LAKE-LEWIN, D. & MEYERS, J.E. (1982). Intensive treatment of multiple myeloma. In: Controversies in Oncology, Wiernik, P.H. (Ed), p.61, John Wiley & Sons: New York."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3171\/jns.1978.49.6.0839","article-title":"The neurosurgical management of spinal metastases causing cord and cauda equina compression","volume":"49","author":"LIVINGSTON, K.E.; PERRIN, R.G.","year":"1978","unstructured":"LIVINGSTON, K.E. & PERRIN, R.G. (1978). The neurosurgical management of spinal metastases causing cord and cauda equina compression; Journal of Neurosurgery, 49, 839.","journal-title":"Journal of Neurosurgery"},{"issue":"270","key":"ref_27","first-page":"1","article-title":"Comparison of standard (MP) with intensive (VBMCP) therapy for the treatment of multiple myeloma (MM)","volume":"3","author":"TSIATIS, O.K.E.N.M.M.; A., A.B.R.A.M.S.O.N.; N.; GLICK, J.","year":"1984","unstructured":"OKEN. M.M.. TSIATIS, A., ABRAMSON, N. & GLICK, J. (1984). Comparison of standard (MP) with intensive (VBMCP) therapy for the treatment of multiple myeloma (MM). Proceedings of the American Society of Clinical Oncology, 3, 270 (abstract C-1055). OSGOOD, E.E. (1960). The survival time of patients with plasmacytic myeloma. Cancer Chemotherapy Reports, 9, 1.","journal-title":"Proceedings of the American Society of Clinical Oncology; The survival time of patients with plasmacytic myeloma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000206984","article-title":"Identical twin marrow transplantation in multiple myeloma","volume":"68","author":"OSSERMAN, E.F.; DIRE, L.B.; DIRE, J.; SHERMAN, W.H.; HERSMAN, J.A.; STORB, R.","year":"1982","unstructured":"OSSERMAN, E.F., DIRE, L.B., DIRE, J., SHERMAN, W.H., HERSMAN, J.A. & STORB, R. (1982). Identical twin marrow transplantation in multiple myeloma. Acta Haematologica, 68, 215.","journal-title":"Acta Haematologica"},{"key":"ref_29","first-page":"241","article-title":"Randomized trial of melphalan, prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU and vincristine in untreated multiple myeloma. Journal ofClinical Oncology","volume":"108","author":"PIZZOLATTO, M.","year":"1984","unstructured":"& PIZZOLATTO, M. (1984). Randomized trial of melphalan, prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU and vincristine in untreated multiple myeloma. Journal ofClinical Oncology (in press). RUSSELL, R.G.G. & FLEISCH, H. (1975). Pyrophosphate and diphosphonates in skeletal metabolism: Physiological, clinical and therapeutic aspects. Clinical Orthopedics, 108, 241.","journal-title":"Clinical Orthopedics; Pyrophosphate and diphosphonates in skeletal metabolism: Physiological, clinical and therapeutic aspects"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.1983.1.8.453","article-title":"Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: A Southwest Oncology Group Study","volume":"1","author":"SALMON, S.E.; HAUT, A.; BONNET, J.; M., A.M.A.R.E.; WEICK, J.K.; DURIE, B.G.M.; DIXON, D.O.","year":"1983","unstructured":"SALMON, S.E., HAUT, A., BONNET, J., AMARE. M., WEICK, J.K., DURIE, B.G.M. & DIXON, D.O. (1983). Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: A Southwest Oncology Group Study. Journal of Clinical Oncology, 1, 453.","journal-title":"Journal of Clinical Oncology"},{"key":"ref_31","first-page":"179","article-title":"Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma","volume":"51","author":"SALMON, S.E.; SHADDUCK, R.K.; SCHILLING, A.","year":"1967","unstructured":"SALMON, S.E., SHADDUCK, R.K. & SCHILLING, A. (1967). Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. Cancer Chemotherapy Reports, 51, 179.","journal-title":"Cancer Chemotherapy Reports"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archinte.1975.00330010149019","article-title":"Remission maintenance therapy for multiple myeloma","volume":"135","author":"STUDY, S.O.U.T.H.W.E.S.T.O.N.C.O.L.O.G.Y.G.R.O.U.P.","year":"1975","unstructured":"SOUTHWEST ONCOLOGY GROUP STUDY (1975). Remission maintenance therapy for multiple myeloma. Archives of Internal Medicine, 135, 147.","journal-title":"Archives of Internal Medicine"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/61\/712\/109\/50155922\/postgradmedj-61-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/61\/712\/109\/50155922\/postgradmedj-61-109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T12:10:23Z","timestamp":1683202223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/61\/712\/109\/7046771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,2,1]]},"references-count":32,"journal-issue":{"issue":"712","published-online":{"date-parts":[[1985,2,1]]},"published-print":{"date-parts":[[1985,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.61.712.109","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1985,2]]},"published":{"date-parts":[[1985,2,1]]}}}